Sawai Group Holdings Co., Ltd. (TYO:4887)
2,420.00
+12.50 (0.52%)
Dec 29, 2025, 3:30 PM JST
Sawai Group Holdings Revenue
Sawai Group Holdings had revenue of 49.33B JPY in the quarter ending September 30, 2025, with 13.30% growth. This brings the company's revenue in the last twelve months to 200.00B, up 12.78% year-over-year. In the fiscal year ending March 31, 2025, Sawai Group Holdings had annual revenue of 189.02B with 6.88% growth.
Revenue (ttm)
200.00B
Revenue Growth
+12.78%
P/S Ratio
1.40
Revenue / Employee
60.42M
Employees
3,310
Market Cap
279.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 189.02B | 12.16B | 6.88% |
| Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
| Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
| Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
| Mar 31, 2021 | 187.22B | 4.68B | 2.56% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |